Ventas 为 650 年到期的 5.10% 优先票据定价 2029 亿加元

芝加哥-(美国商业资讯)-Ventas, Inc.（纽约证券交易所股票代码：VTR）（“Ventas”或“公司”）今天表示，其在加拿大的私募发行定价为 650 加元 百万年息 5.10% 的 J 系列优先票据，将于 2029 年到期（“票据”）。如果满足惯例成交条件，票据的销售预计将于 5 年 2024 月 XNUMX 日结束。

这些票据由 Ventas 的间接全资子公司 Ventas Canada Finance Limited（“发行人”）在招股说明书豁免的基础上仅向非个人的“合格投资者”发行，除非此类个人也是“获准客户” ，”在每种情况下均根据适用的加拿大证券法进行定义。该票据将由公司无条件担保（“担保”）。

这些票据将于5年2029月5日到期。这些票据将构成发行人的高级无担保债务，并将与发行人所有其他当前和未来的无担保和非次级债务享有同等地位。该担保将构成担保人的高级无担保债务，并将与公司所有其他当前和未来的无担保和非次级债务享有同等地位。自 5 年 5 月 2024 日起，票据利息将于每年 1 月 XNUMX 日和 XNUMX 月 XNUMX 日支付，每半年支付一次。预计票据将被标准普尔评为 BBB+（稳定），穆迪将评级为 BaaXNUMX（稳定），惠誉评级 BBB（稳定）。

发行人拟使用本次票据发行所得款项净额 偿还发行人现有债务（包括 500 亿加元无担保定期贷款融资）下的未偿金额，以及用于其他一般公司用途。

该票据尚未且不会根据经修订的 1933 年证券法（“证券法”）或任何州证券法进行注册，并且在未注册或未获得适用豁免的情况下不得在美国发行或出售。 《证券法》和适用州法律的注册要求。该票据尚未通过加拿大任何省或地区的招股说明书进行资格认证，并且不得向位于加拿大或居住在加拿大的人士发售或出售，除非适用加拿大证券法招股说明书要求的豁免。

本新闻稿不构成出售或购买任何证券的要约或购买或出售任何证券的要约的征求，也不构成在此类要约、征求、出售的任何司法管辖区内的任何证券的要约、征求、出售或购买否则购买将是非法的。

Ventas Inc.（纽约证券交易所股票代码：VTR）是一家领先的标准普尔 500 指数房地产投资信托公司，致力于通过创造有利于大量且不断增长的老龄化人口的卓越环境来提供强劲、可持续的股东回报。该公司的增长得益于其老年住房社区，这些社区为居民提供有价值的服务，使他们能够在支持的环境中茁壮成长。 Ventas 利用其无与伦比的运营专业知识以及来自 Ventas Operations Insights 的数据驱动见解^TM 平台、广泛的关系和强大的财务状况，以实现其在约 1,400 处房产中提供卓越业绩的目标。 Ventas 的投资组合由北美和英国的老年住宅社区、门诊医疗大楼、研究中心和医疗设施组成。公司受益于一支经验丰富、才华横溢的专业团队，他们共同致力于卓越、诚信和帮助人们活得更长久、更健康、更幸福的共同目标。

本新闻稿包含《证券法》第 27A 条和《21 年证券交易法》修订版第 1934E 条含义内的前瞻性陈述以及适用加拿大证券法含义内的前瞻性信息（统称为“前瞻性信息”）。 -看起来的陈述”）。这些前瞻性陈述包括但不限于预期、信念、未来计划和战略、运营和发展的预期结果以及其他非历史事实的陈述。前瞻性陈述包括，除其他外，有关我们和我们的官员的意图、信念或期望的陈述，通过使用“假设”、“可能”、“将”、“项目”、“期望”等词语来识别。 “相信”、“打算”、“预期”、“寻求”、“目标”、“预测”、“计划”、“潜力”、“机会”、“估计”、“可以”、“会”、“应该”以及其他类似的派生术语或其否定词。

前瞻性陈述基于管理层的信念以及有关未来事件的一些假设。您不应过度依赖这些前瞻性陈述，这些陈述不是业绩的保证，并受到许多不确定性和其他因素的影响，这些因素可能导致实际事件或结果与前瞻性陈述所明示或暗示的内容存在重大差异。寻找陈述。我们不承担更新这些前瞻性声明的责任，这些声明仅代表发布之日的情况。我们敦促您仔细审查我们所披露的有关可能影响我们业务和未来财务业绩的风险和不确定性的信息， 包括下文以及我们向美国证券交易委员会提交的文件中的内容，例如我们的报告中标题为“警示性声明——风险因素摘要”、“风险因素”以及“管理层对财务状况和经营业绩的讨论与分析”的部分。截至 10 年 31 月 2023 日的年度 XNUMX-K 表格年度报告。

Certain factors that could affect our future results and our ability to achieve our stated goals include, but are not limited to: (a) our ability to achieve the anticipated benefits and synergies from, and effectively integrate, our completed or anticipated acquisitions and investments of properties, including our ownership of the properties included in our equitized loan portfolio; (b) our exposure and the exposure of our tenants, managers and borrowers to complex healthcare and other regulation, including evolving laws and regulations regarding data privacy and cybersecurity and environmental matters, and the challenges and expense associated with complying with such regulation; (c) the potential for significant general and commercial claims, legal actions, regulatory proceedings or enforcement actions that could subject us or our tenants, managers or borrowers to increased operating costs, uninsured liabilities, fines or significant operational limitations, including the loss or suspension of or moratoriums on accreditations, licenses or certificates of need, suspension of or nonpayment for new admissions, denial of reimbursement, suspension, decertification or exclusion from federal, state or foreign healthcare programs or the closure of facilities or communities; (d) the impact of market and general economic conditions on us, our tenants, managers and borrowers and in areas in which our properties are geographically concentrated, including macroeconomic trends and financial market events, such as bank failures and other events affecting financial institutions, market volatility, increases in inflation, changes in or elevated interest and exchange rates, tightening of lending standards and reduced availability of credit or capital, geopolitical conditions, supply chain pressures, rising labor costs and historically low unemployment, events that affect consumer confidence, our occupancy rates and resident fee revenues, and the actual and perceived state of the real estate markets, labor markets and public and private capital markets; (e) our reliance and the reliance of our tenants, managers and borrowers on the financial, credit and capital markets and the risk that those markets may be disrupted or become constrained, including as a result of bank failures or concerns or rumors about such events, tightening of lending standards and reduced availability of credit or capital; (f) the secondary and tertiary effects of the COVID-19 pandemic on our business, financial condition and results of operations and the implementation and impact of regulations related to the CARES Act and other stimulus legislation, including the risk that some or all of the CARES Act or other COVID-19 relief payments we or our tenants, managers or borrowers received could be recouped; (g) our ability, and the ability of our tenants, managers and borrowers, to navigate the trends impacting our or their businesses and the industries in which we or they operate, and the financial condition or business prospect of our tenants, managers and borrowers; (h) the risk of bankruptcy, inability to obtain benefits from governmental programs, insolvency or financial deterioration of our tenants, managers, borrowers and other obligors which may, among other things, have an adverse impact on the ability of such parties to make payments or meet their other obligations to us, which could have an adverse impact on our results of operations and financial condition; (i) the risk that the borrowers under our loans or other investments default or that, to the extent we are able to foreclose or otherwise acquire the collateral securing our loans or other investments, we will be required to incur additional expense or indebtedness in connection therewith, that the assets will underperform expectations or that we may not be able to subsequently dispose of all or part of such assets on favorable terms; (j) our current and future amount of outstanding indebtedness, and our ability to access capital and to incur additional debt which is subject to our compliance with covenants in instruments governing our and our subsidiaries’ existing indebtedness; (k) the recognition of reserves, allowances, credit losses or impairment charges are inherently uncertain, may increase or decrease in the future and may not represent or reflect the ultimate value of, or loss that we ultimately realize with respect to, the relevant assets, which could have an adverse impact on our results of operations and financial condition; (l) the non-renewal of any leases or management agreement or defaults by tenants or managers thereunder and the risk of our inability to replace those tenants or managers on a timely basis or on favorable terms, if at all; (m) our ability to identify and consummate future investments in or dispositions of healthcare assets and effectively manage our portfolio opportunities and our investments in co-investment vehicles, joint ventures and minority interests, including our ability to dispose of such assets on favorable terms as a result of rights of first offer or rights of first refusal in favor of third parties; (n) risks related to development, redevelopment and construction projects, including costs associated with inflation, rising or elevated interest rates, labor conditions and supply chain pressures, and risks related to increased construction and development in markets in which our properties are located, including adverse effect on our future occupancy rates; (o) our ability to attract and retain talented employees; (p) the limitations and significant requirements imposed upon our business as a result of our status as a REIT and the adverse consequences (including the possible loss of our status as a REIT) that would result if we are not able to comply with such requirements; (q) the ownership limits contained in our certificate of incorporation with respect to our capital stock in order to preserve our qualification as a REIT, which may delay, defer or prevent a change of control of our company; (r) the risk of changes in healthcare law or regulation or in tax laws, guidance and interpretations, particularly as applied to REITs, that could adversely affect us or our tenants, managers or borrowers; (s) increases in our borrowing costs as a result of becoming more leveraged, including in connection with acquisitions or other investment activity and rising or elevated interest rates; (t) our reliance on third-party managers and tenants to operate or exert substantial control over properties they manage for or rent from us, which limits our control and influence over such operations and results; (u) our exposure to various operational risks, liabilities and claims from our operating assets; (v) our dependency on a limited number of tenants and managers for a significant portion of our revenues and operating income; (w) our exposure to particular risks due to our specific asset classes and operating markets, such as adverse changes affecting our specific asset classes and the real estate industry, the competitiveness or financial viability of hospitals on or near the campuses where our outpatient medical buildings are located, our relationships with universities, the level of expense and uncertainty of our research tenants, and the limitation of our uses of some properties we own that are subject to ground lease, air rights or other restrictive agreements; (x) the risk of damage to our reputation; (y) the availability, adequacy and pricing of insurance coverage provided by our policies and policies maintained by our tenants, managers or other counterparties; (z) the risk of exposure to unknown liabilities from our investments in properties or businesses; (aa) the occurrence of cybersecurity threats and incidents that could disrupt our or our tenants’, managers’ or borrower’s operations, result in the loss of confidential or personal information or damage our business relationships and reputation; (bb) the failure to maintain effective internal controls, which could harm our business, results of operations and financial condition; (cc) the impact of merger, acquisition and investment activity in the healthcare industry or otherwise affecting our tenants, managers or borrowers; (dd) disruptions to the management and operations of our business and the uncertainties caused by activist investors; (ee) the risk of catastrophic or extreme weather and other natural events and the physical effects of climate change; (ff) the risk of potential dilution resulting from future sales or issuances of our equity securities; and (gg) the other factors set forth in our periodic filings with the Securities and Exchange Commission.

联系我们

文塔斯公司

BJ·格兰特

[877] 4 文塔斯

• SEO 支持的内容和 PR 分发。 今天得到放大。
• PlatoData.Network 垂直生成人工智能。 赋予自己力量。 访问这里。
• 柏拉图爱流。 Web3 智能。 知识放大。 访问这里。
• 柏拉图ESG。 碳， 清洁科技, 能源， 环境， 太阳能， 废物管理。 访问这里。
• 柏拉图健康。 生物技术和临床试验情报。 访问这里。
• Sumber: https://www.fintechnews.org/ventas-prices-cdn650-million-of-5-10-senior-notes-due-2029/